Literature DB >> 8200230

Fulminant amebic colitis. A morphologic study of four cases.

D Chun1, P Chandrasoma, M Kiyabu.   

Abstract

PURPOSE: The morphologic features of fulminant amebic colitis are poorly documented. In this report, we describe the clinical and pathologic findings in four of these cases.
METHODS: The surgical pathology reports and accompanying histologic slides were examined from four patients who underwent surgical resections for fulminant amebic colitis. Clinical information was obtained from the patients' medical records.
RESULTS: Large, geographic mucosal ulcers were typically present and were accompanied by yellow-green pseudomembranes. The muscularis externa was usually attenuated and necrotic, imparting a "wet blotting paper" consistency. Large numbers of amebic trophozoites were present within the inflammatory exudates. The mucosa adjacent to and undermined by the ulcers was often hemorrhagic or inflamed, resembling ischemic colitis or idiopathic inflammatory bowel disease, respectively. Two patients died within four weeks of their surgery. A third patient died one year later as a result of AIDS-related complications. The remaining patient has been lost to follow-up.
CONCLUSION: An uncommon but life-threatening manifestation of intestinal amebiasis is a fulminant colitis. Early surgical intervention and intensive antiamebic chemotherapy are essential for efficacious management.

Entities:  

Mesh:

Year:  1994        PMID: 8200230     DOI: 10.1007/bf02050986

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  Colonic perforation in unsuspected amebic colitis.

Authors:  M A Abbas; D C Mulligan; N N Ramzan; J E Blair; J D Smilack; M S Shapiro; T K Lidner; K W Olden
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

Review 2.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.